Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
6 participants
INTERVENTIONAL
2004-09-30
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer-Based Therapy for Mild Cognitive Impairment
NCT00319943
Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease
NCT00611312
Computerized Cognitive Training Program for Older Persons With Mild Dementia
NCT02671630
Cognitive Training and Practice Effects in Mild Cognitive Impairment
NCT02301546
Computer-Based Training for Cognitive Enhancement: Classroom Study
NCT00337909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computer-based Cognitive Training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mini-Mental Status Examination (MMSE) score of 22 or higher.
* Adequate visual capacity.
* Adequate hearing capacity.
* Has a caregiver with some computer experience.
* Willing and able to commit to the time requirement of the entire study.
Exclusion Criteria
* Participant is planning to begin acetylcholinesterase inhibitor (AChEI) therapy.
* Participants with severe tremor.
* Axis 1 or 2 psychiatric disorders.
* History of substance abuse.
* History of head trauma.
60 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Posit Science Corporation
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joel Kramer, PsyD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Kristine Yaffe, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, San Francisco
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OUT-109-2005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.